Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT ) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROCEPT BIOROBOTICS CORPORATION (PRCT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On February 25, 2026, Procept reported fourth quarter and full year 2025 results, disclosing a larger-than-expected adjusted EBITDA loss and cutting its full-year 2026 revenue guidance to a range of $390 million to $410 million (down from its prior range of $410 million to $430 million). The Company attributed lower U.S. consumable revenue in part to eliminating its historical practice of providing discounts on bulk purchases in order to better align handpiece sales with procedure volumes.

On this news, Procept’s stock price fell $4.21 per share, or 15.12%, to close at $23.63 per share on February 26, 2026, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Procept securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Email us at: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com .
Follow us for updates on Twitter at twitter.com/FRC_LAW .

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309108760/en/